Back to Report Store Home

Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018

  • Published: Apr-2018
  • Report Code: GBIHC033IDB
  • Report Format: pdf

Description

List of Tables

Table 1: Number of Products under Development for Respiratory Syncytial Virus (RSV) Infections

Table 2: Number of Products under Development by Companies, Respiratory Syncytial Virus (RSV) Infections

Table 3: Number of Products under Development by Universities/Institutes, Respiratory Syncytial Virus (RSV) Infections

Table 4: Products under Development by Companies, Respiratory Syncytial Virus (RSV) Infections

Table 5: Products under Development by Universities/Institutes, Respiratory Syncytial Virus (RSV) Infections

Table 6: Number of Products under Development for Human Parainfluenza Virus 3 Infections

Table 7: Number of Products under Development by Companies, Human Parainfluenza Virus 3 Infections

Table 8: Number of Products under Development by Universities/Institutes, Human Parainfluenza Virus 3 Infections

Table 9: Products under Development by Companies, Human Parainfluenza Virus 3 Infections

Table 10: Products under Development by Universities/Institutes, Human Parainfluenza Virus 3 Infections

Table 11: Number of Products by Stage and Target, Respiratory Syncytial Virus (RSV) Infections

Table 12: Number of Products by Stage and Mechanism of Action, Respiratory Syncytial Virus (RSV) Infections

Table 13: Number of Products by Stage and Route of Administration, Respiratory Syncytial Virus (RSV) Infections

Table 14: Number of Products by Stage and Molecule Type, Respiratory Syncytial Virus (RSV) Infections

Table 15: Number of Products by Stage and Target, Human Parainfluenza Virus 3 Infections

Table 16: Number of Products by Stage and Mechanism of Action, Human Parainfluenza Virus 3 Infections

Table 17: Number of Products by Stage and Route of Administration, Human Parainfluenza Virus 3 Infections

Table 18: Number of Products by Stage and Molecule Type, Human Parainfluenza Virus 3 Infections

Table 19: Respiratory Syncytial Virus (RSV) Infections – Pipeline by 3-V Biosciences Inc,

Table 20: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Abivax SA

Table 21: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Ablynx NV

Table 22: Respiratory Syncytial Virus (RSV) Infections – Pipeline by ADMA Biologics Inc

Table 23: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Agilvax Inc

Table 24: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Amarillo Biosciences Inc

Table 25: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Anima Biotech Ltd

Table 26: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Aridis Pharmaceuticals LLC

Table 27: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Artificial Cell Technologies Inc

Table 28: Respiratory Syncytial Virus (RSV) Infections – Pipeline by AstraZeneca Plc

Table 29: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Bavarian Nordic A/S

Table 30: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Celltrion Inc

Table 31: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Curevac AG

Table 32: Respiratory Syncytial Virus (RSV) Infections – Pipeline by DBV Technologies SA

Table 33: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Enanta Pharmaceuticals Inc

Table 34: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Evec Inc

Table 35: Respiratory Syncytial Virus (RSV) Infections – Pipeline by F. Hoffmann-La Roche Ltd

Table 36: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Gene Techno Science Co Ltd

Table 37: Respiratory Syncytial Virus (RSV) Infections – Pipeline by GenVec Inc

Table 38: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Gilead Sciences Inc

Table 39: Respiratory Syncytial Virus (RSV) Infections – Pipeline by GlaxoSmithKline Plc

Table 40: Respiratory Syncytial Virus (RSV) Infections – Pipeline by iBio Inc

Table 41: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Immunovaccine Inc

Table 42: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Immunwork Inc

Table 43: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Inovio Pharmaceuticals Inc

Table 44: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Johnson & Johnson

Table 45: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Karyopharm Therapeutics Inc

Table 46: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Kineta Inc

Table 47: Respiratory Syncytial Virus (RSV) Infections – Pipeline by mAbxience SA

Table 48: Respiratory Syncytial Virus (RSV) Infections – Pipeline by MedImmune LLC

Table 49: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Medivir AB

Table 50: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Mymetics Corp

Table 51: Respiratory Syncytial Virus (RSV) Infections – Pipeline by NanoBio Corp

Table 52: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Navigen Inc

Table 53: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Novavax Inc

Table 54: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Phoenix Biotechnology Inc

Table 55: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Profectus BioSciences Inc

Table 56: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Pulmocide Ltd

Table 57: Respiratory Syncytial Virus (RSV) Infections – Pipeline by ReViral Ltd

Table 58: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Romark Laboratories LC

Table 59: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Takeda Pharmaceutical Co Ltd

Table 60: Respiratory Syncytial Virus (RSV) Infections – Pipeline by TechnoVax Inc

Table 61: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Themis Bioscience GmbH

Table 62: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Vault Pharma Inc

Table 63: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Vaxart Inc

Table 64: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Virometix AG

Table 65: Respiratory Syncytial Virus (RSV) Infections – Pipeline by Visterra Inc

Table 66: Respiratory Syncytial Virus (RSV) Infections – Pipeline by VLP Biotech Inc

Table 67: Human Parainfluenza Virus 3 Infections – Pipeline by 3-V Biosciences Inc

Table 68: Human Parainfluenza Virus 3 Infections – Pipeline by Amarillo Biosciences Inc

Table 69: Human Parainfluenza Virus 3 Infections – Pipeline by Ansun Biopharma Inc

Table 70: Human Parainfluenza Virus 3 Infections – Pipeline by Moderna Therapeutics Inc

Table 71: Respiratory Syncytial Virus (RSV) Infections – Dormant Projects

Table 72: Human Parainfluenza Virus 3 Infections – Dormant Projects

Table 73: Respiratory Syncytial Virus (RSV) Infections – Discontinued Products

Table 74: Human Parainfluenza Virus 3 Infections – Discontinued Products

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$11985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards